ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,358Medicare Part D Prescriptions Filled, Including Refills

Rank: 245 out of 6645

$946K Total Retail Price of All Prescriptions

Rank: 362 out of 6645

774 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 774 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

24% of this provider’s 774 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 11,888 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LISINOPRIL 933 684 1 3
SIMVASTATIN 921 694 2 1
HYDROCODONE-ACETAMINOPHEN 775 477 S3 3 5
LEVOTHYROXINE SODIUM 588 426 4 4
AMLODIPINE BESYLATE 418 322 5 2
OMEPRAZOLE 405 266 6 6
METFORMIN HCL 388 275 7 7
FUROSEMIDE 356 266 8 11
GABAPENTIN 333 211 9 18
TRAMADOL HCL 311 221 10 30
ATENOLOL 287 229 11 8
GLIMEPIRIDE 285 184 12 47
CARVEDILOL 278 199 13 25
MELOXICAM 263 172 14 46
HYDROCHLOROTHIAZIDE 252 201 15 9
MORPHINE SULFATE ER 251 100 S2 16 124
LOVASTATIN 219 173 17 15
ZOLPIDEM TARTRATE 205 138 18 17
SERTRALINE HCL 187 100 19 43
OXYCODONE-ACETAMINOPHEN 183 92 S2 20 150
LOSARTAN POTASSIUM 176 140 21 12
OXYCODONE HCL-ACETAMINOPHEN 174 75 S2 22 213
TRAZODONE HCL 168 83 23 60
METOPROLOL SUCCINATE 165 110 24 24
METOPROLOL TARTRATE 152 140 25 13
TRIAMTERENE-HCTZ 146 106 26 52
CRESTOR 143 87 27 34
CLONIDINE HCL 134 97 28 56
WARFARIN SODIUM 133 105 29 16
PANTOPRAZOLE SODIUM 132 72 30 29
CYCLOBENZAPRINE HCL 131 35 R 31 157
PAROXETINE HCL 131 87 31 72
KLOR-CON 8 130 90 33 123
DIGOXIN 124 108 34 59
DIOVAN 118 115 35 19
SPIRIVA 118 89 35 65
ALLOPURINOL 113 92 37 31
POTASSIUM CHLORIDE 111 92 38 28
CITALOPRAM HBR 110 66 39 35
CARISOPRODOL 106 20 R 40 94
CYMBALTA 101 65 41 78
ESCITALOPRAM OXALATE 100 37 42 86
ATORVASTATIN CALCIUM 98 55 43 10
BACLOFEN 95 62 44 100
TAMSULOSIN HCL 94 61 45 22
SULFAMETHOXAZOLE-TRIMETHOPRIM 93 64 46 134
CLOPIDOGREL 88 62 47 36
AZITHROMYCIN 86 53 48 44
PLAVIX 86 70 48 49
RANITIDINE HCL 85 57 50 51
BUPROPION HCL SR 83 32 51 296
FLUOXETINE HCL 83 37 51 63
PREDNISONE 81 61 53 57
EVISTA 81 65 53 90
ALENDRONATE SODIUM 80 77 55 14
FENTANYL 78 18 S2 56 141
ADVAIR DISKUS 76 48 57 45
RISPERIDONE 76 34 57 93
DIOVAN HCT 72 65 59 64
TRIAMTERENE-HYDROCHLOROTHIAZID 72 50 59 143
GEMFIBROZIL 72 49 59 96
TERAZOSIN HCL 70 64 62 48
LANTUS 69 52 63 50
DONEPEZIL HCL 68 67 64 27
COMBIVENT 65 41 65 174
NEXIUM 65 32 65 40
ISOSORBIDE MONONITRATE ER 64 63 67 66
ZETIA 64 21 67 87
ALPRAZOLAM 61 61 69 195
DILTIAZEM 24HR CD 61 52 69 176
LAMOTRIGINE 61 0 69 284
NAMENDA 58 58 72 41
PROAIR HFA 58 33 72 32
INSULIN SYRINGE 57 37 74 61
TRIAMCINOLONE ACETONIDE 55 34 75 55
FENOFIBRATE 53 38 76 74
LEVOFLOXACIN 53 38 76 83
CEPHALEXIN 52 26 78 111
HYDROCORTISONE 50 44 79 229
SPIRONOLACTONE 50 36 79 85
PROPRANOLOL HCL 50 37 79 151
FLUTICASONE PROPIONATE 50 35 79 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.